Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹500 | ₹500 |
Expense Ratio | 2.25 | 1.96 |
NAV | ₹289.36 | ₹421.68 |
Fund Started | 01 Aug 2005 | 04 Jun 1999 |
Fund Size | ₹1167.75 Cr | ₹3202.66 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 56.86% | 50.53% |
3 Year | 19.27% | 21.63% |
5 Year | 29.22% | 30.20% |
1 Year
3 Year
5 Year
Equity | 97.48% | 96.24% |
Cash | 2.41% | 3.76% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 11.47% |
Cipla Ltd. | 6.65% |
Ajanta Pharma Ltd. | 5.56% |
Dr. Reddy's Laboratories Ltd. | 5.24% |
Apollo Hospitals Enterprise Ltd. | 3.84% |
Glenmark Pharmaceuticals Ltd. | 3.71% |
Eris Lifesciences Ltd. | 3.54% |
Aurobindo Pharma Ltd. | 3.36% |
Procter & Gamble Health Ltd. | 3.31% |
Fortis Healthcare Ltd. | 3.00% |
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 11.94% |
Divi's Laboratories Ltd. | 5.73% |
Lupin Ltd. | 5.60% |
Max Healthcare Institute Ltd. | 5.44% |
Cipla Ltd. | 5.17% |
Lonza Group Ag | 5.13% |
Poly Medicure Ltd. | 4.66% |
Krishna Institute of Medical Sciences Ltd | 3.95% |
Aether Industries Ltd. | 3.89% |
Jupiter Life Line Hospitals Ltd. | 3.76% |
Name | Kamal Gada | Tanmaya Desai |
Start Date | 02 May 2022 | 27 Jun 2011 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 01 Aug 2005 | 04 Jun 1999 |
Description
Launch Date